Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1995 | 12-1994 | 12-1993 | |
| Sales | 1,160 | 508 | 0 |
| Gross Profit | 1,160 | 508 | N/A |
| Operating Expenses | 240 | 90 | 0 |
| Operating Income | 920 | 418 | N/A |
| Interest Expense | 200 | 170 | 0 |
| Pre-tax Income | 720 | 248 | 0 |
| Net Income Continuous | 720 | -1,900 | N/A |
| Net Income | $-1,970 | $-1,930 | $-310 |
| EPS Basic Total Ops | N/A | -662.75 | N/A |
| EPS Basic Continuous Ops | N/A | -655.17 | N/A |
| EPS Diluted Total Ops | N/A | -662.75 | N/A |
| EPS Diluted Continuous Ops | N/A | -655.17 | N/A |
| EBITDA(a) | $1,290 | $638 | $N/A |